去年，Merit Medical Systems Inc表現最佳的業務類別Peripheral Intervention的營收達到579.84M美元。United States的營收貢獻最高，去年達到909.47M美元。最近一個季度，截至2026-06-30，Merit Medical Systems Inc表現最佳的業務類別Foundational Access的營收達到580.63M美元。United States的營收貢獻最高，達到252.05M美元。

業務

營業收入

佔比

年報

年報

單季報

Peripheral Intervention

Cardiac Intervention

Custom Procedural Solutions

OEM

Endoscopy devices

Catheters

CRM/EP

Embolization devices

Cianna Medical

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Peripheral Intervention

579.84M(38.25%)

552.17M(40.70%)

502.22M(39.94%)

439.81M(25.27%)

405.12M(37.69%)

341.57M(35.44%)

401.47M(40.35%)

Cardiac Intervention

448.91M(29.61%)

370.99M(27.35%)

358.45M(28.51%)

343.19M(19.72%)

320.64M(29.83%)

279.67M(29.02%)

93.14M(9.36%)

Custom Procedural Solutions

209.33M(13.81%)

201.20M(14.83%)

195.33M(15.54%)

190.19M(10.93%)

193.94M(18.05%)

203.20M(21.08%)

149.92M(15.07%)

OEM

204.96M(13.52%)

177.38M(13.08%)

164.56M(13.09%)

145.03M(8.33%)

123.53M(11.49%)

109.77M(11.39%)

129.49M(13.02%)

Endoscopy devices

72.86M(4.81%)

54.77M(4.04%)

36.81M(2.93%)

622.12M(35.75%)

31.52M(2.93%)

29.67M(3.08%)

33.87M(3.40%)

Catheters

--(--)

81.18M(8.16%)

CRM/EP

--(--)

53.49M(5.38%)

Embolization devices

--(--)

52.07M(5.23%)

Cianna Medical

--(--)

212.00K(0.02%)

地區

營業收入

佔比

年報

年報

單季報

United States

International

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

909.47M(59.99%)

800.78M(59.03%)

726.99M(57.82%)

1.24B(71.25%)

608.88M(56.65%)

550.06M(57.07%)

575.71M(57.87%)

International

606.44M(40.01%)

555.73M(40.97%)

530.38M(42.18%)

500.42M(28.75%)

465.87M(43.35%)

413.81M(42.93%)

419.14M(42.13%)